De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

PhytoHealth Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

I-Lin Lee

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	3.2yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	3.4yrs
Gemiddelde ambtstermijn bestuur	4.4yrs

Recente managementupdates

Recent updates

PhytoHealth (TPE:4108) Is In A Good Position To Deliver On Growth Plans

Mar 01

The PhytoHealth (TPE:4108) Share Price Has Gained 60% And Shareholders Are Hoping For More

Jan 07

CEO

I-Lin Lee

3.2yrs

Tenure

I-Lin Lee serves as Director at PhytoHealth Corporation since May 26, 2020 and serves as its President since August 4, 2021. I-Lin Lee experience includes PhytoHealth Corporation AmCad BioMed Corporation L...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Yi-Li Lee	Chairman	4.2yrs	NT$2.45m	0.15% NT$ 5.4m
I-Lin Lee	President & Director	3.2yrs	geen gegevens	geen gegevens
Chih Yuan Huang	Financial & Accounting Officer	3.4yrs	geen gegevens	geen gegevens
Kevin Lin	Manager of Administration Division	no data	geen gegevens	geen gegevens
Fred Lai	Managing Director	no data	geen gegevens	geen gegevens
Li Feng Yeh	Chief Internal Officer	3.4yrs	geen gegevens	geen gegevens

3.4yrs

Gemiddelde duur

Ervaren management: Het managementteam van 4108 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Yi-Li Lee	Chairman	4.2yrs	NT$2.45m	0.15% NT$ 5.4m
I-Lin Lee	President & Director	4.4yrs	geen gegevens	geen gegevens
Chen-Chia Lee	Director	no data	geen gegevens	0.15% NT$ 5.4m
Der Shan Wang	Independent Director	no data	NT$290.00k	geen gegevens
Sun-Quae Lai	Independent Director	no data	NT$275.00k	geen gegevens
Yu-Ju Lai	Director	4.4yrs	NT$260.00k	geen gegevens
Ming-Fu Wang	Director	4.4yrs	NT$260.00k	geen gegevens
Shoei-Loong Lin	Independent Director	4.4yrs	NT$290.00k	geen gegevens
Tse-Hung Huang	Director	4.4yrs	NT$260.00k	geen gegevens
Ching-Chung Tsai	Director	4.4yrs	NT$260.00k	0.00086% NT$ 30.8k
Yang-Chang Wu	Independent Director	1.4yrs	geen gegevens	geen gegevens
Pai-Sen Wang	Director	1.4yrs	NT$255.00k	geen gegevens

4.4yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van 4108 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.4 jaar).

PhytoHealth Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

PhytoHealth Corporation, Annual General Meeting, May 28, 2024

PhytoHealth Corporation Announces the Resignation of Chen Wen-Hwa as Legal Representative and Director

PhytoHealth Corporation Elects Wang Pai-Sen as a Director

PhytoHealth Corporation Appoints Wu Yang-Chang as Independent Director

PhytoHealth Corporation, Annual General Meeting, May 24, 2022

Recent updates

Second quarter 2024 earnings released: NT$0.08 loss per share (vs NT$0.076 loss in 2Q 2023)

PhytoHealth Corporation to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: NT$0.14 loss per share (vs NT$0.037 loss in 1Q 2023)

PhytoHealth Corporation to Report Q1, 2024 Results on May 03, 2024

Full year 2023 earnings released: NT$0.24 loss per share (vs NT$0.40 loss in FY 2022)

PhytoHealth Corporation, Annual General Meeting, May 28, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: NT$0.037 (vs NT$0.02 in 3Q 2022)

New minor risk - Share price stability

PhytoHealth Corporation Announces the Resignation of Chen Wen-Hwa as Legal Representative and Director

Second quarter 2023 earnings released: NT$0.07 loss per share (vs NT$0.092 loss in 2Q 2022)

PhytoHealth Corporation Elects Wang Pai-Sen as a Director

PhytoHealth Corporation Appoints Wu Yang-Chang as Independent Director

Full year 2022 earnings released: NT$0.40 loss per share (vs NT$0.40 loss in FY 2021)

Second quarter 2022 earnings released: NT$0.10 loss per share (vs NT$0.13 loss in 2Q 2021)

First quarter 2022 earnings released: NT$0.14 loss per share (vs NT$0.14 loss in 1Q 2021)

PhytoHealth Corporation Announces R&D Progress of the One New Drugs Currently in Development

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

PhytoHealth Corporation, Annual General Meeting, May 24, 2022

Third quarter 2021 earnings released: EPS NT$0.04 (vs NT$0.18 loss in 3Q 2020)

Director & President Chien-Hsin Cheng has left the company

Second quarter 2021 earnings released: NT$0.13 loss per share (vs NT$0.018 profit in 2Q 2020)

First quarter 2021 earnings released: NT$0.14 loss per share (vs NT$0.22 loss in 1Q 2020)

PhytoHealth (TPE:4108) Is In A Good Position To Deliver On Growth Plans

Full year 2020 earnings released: NT$0.54 loss per share (vs NT$1.04 loss in FY 2019)

Phytohealth Corporation Announces Current R&D Progress on PG2, Anti-Osteoporosis, and Moderate to Severe Pain Relief New Drugs

New 90-day high: NT$30.80

The PhytoHealth (TPE:4108) Share Price Has Gained 60% And Shareholders Are Hoping For More

New 90-day high: NT$28.10

New 90-day low: NT$23.35

New 90-day low: NT$23.40

Third quarter 2020 earnings released: NT$0.18 loss per share

New 90-day low: NT$24.70

New 90-day low: NT$25.15

New 90-day low: NT$26.70

First half earnings released

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur